Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 3.93%
March 31, 2026 4.24%
December 31, 2025 3.26%
September 30, 2025 3.11%
June 30, 2025 3.30%
March 31, 2025 3.47%
December 31, 2024 2.78%
September 30, 2024 2.74%
June 30, 2024 2.81%
March 31, 2024 3.30%
December 31, 2023 2.98%
September 30, 2023 2.77%
June 30, 2023 2.80%
March 31, 2023 3.24%
December 31, 2022 3.06%
September 30, 2022 2.97%
June 30, 2022 3.07%
March 31, 2022 3.57%
December 31, 2021 3.16%
September 30, 2021 3.17%
June 30, 2021 3.57%
March 31, 2021 2.91%
December 31, 2020 2.58%
September 30, 2020 2.54%
June 30, 2020 2.49%
Date Value
March 31, 2020 2.73%
December 31, 2019 2.34%
September 30, 2019 2.35%
June 30, 2019 2.48%
March 31, 2019 2.88%
December 31, 2018 2.40%
September 30, 2018 2.11%
June 30, 2018 2.45%
March 31, 2018 2.77%
December 31, 2017 2.49%
September 30, 2017 2.73%
June 30, 2017 2.53%
March 31, 2017 3.12%
December 31, 2016 2.46%
September 30, 2016 2.74%
June 30, 2016 2.42%
March 31, 2016 2.75%
December 31, 2015 2.37%
September 30, 2015 2.54%
June 30, 2015 2.28%
March 31, 2015 2.55%
December 31, 2014 2.09%
September 30, 2014 2.61%
June 30, 2014 2.12%
March 31, 2014 2.40%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Cardinal Health, Inc. 3.87%
McKesson Corp. 3.31%
Henry Schein, Inc. 29.81%
CVS Health Corp. 14.85%
Accendra Health, Inc. 37.62%